Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia

N. Môri, Mitsuya Katayama, Shigenari Nukaga

Journal of Microbiology Immunology and Infection · 2020 · 14 citations · 6 references

DOIFull text

Open access

Concepts

Abstract

No specific therapy is available for COVID-19. We report the effectiveness and adverse effects of triple therapy with hydroxychloroquine, azithromycin, and ciclesonide in patients with COVID-19 pneumonia. The clinical condition of the patients improved within 5 days in response to the therapy.

References

6